European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Deliverables

Midterm report on the evaluation of risk factors related to HBVinduced HCC

A Quality Assurance Plan

Midterm recruitment report of GBC patients

Third dissemination report

Midterm recruitment report of HCC patients and patients at risk of developing HCC

First dissemination report

Report of the kick-off meeting

Midterm recruitment report of CCA patients and patients predisposed to develop CCA

Second dissemination report

Public website and social media profiles

Completion of trainings at all sites

Searching for OpenAIRE data...

Publications

Medical therapy of HCC

Author(s): Vogel A, Saborowski A.
Published in: Journal of Hepatology, 2021, ISSN 0168-8278
Publisher: Elsevier BV
DOI: 10.1016/j.jhep.2021.05.017

Next-Generation Biomarkers for Cholangiocarcinoma

Author(s): Pedro Miguel Rodrigues, Arndt Vogel, Marco Arrese, Domingo C. Balderramo, Juan W. Valle, Jesus Maria Banales
Published in: Cancers, 2021, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13133222

Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review.

Author(s): Rohan Shotton, Angela Lamarca, Juan Valle, Mairéad G McNamara.
Published in: World Journal of Gastrointestinal Oncology., 2021, ISSN 1948-5204
Publisher: Baishideng Publishing Group
DOI: 10.4251/wjgo.v13.i9.1073

Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia

Author(s): Lorena Rosa, Lorena Lobos‐González, Natalia Muñoz‐Durango, Patricia García, Carolina Bizama, Natalia Gómez, Ximena González, Ignacio A. Wichmann, Nicolás Saavedra, Francisca Guevara, Jaime Villegas, Marco Arrese, Catterina Ferreccio, Alexis M. Kalergis, Juan Francisco Miquel, Jaime A. Espinoza, Juan C. Roa
Published in: Molecular Oncology, 2020, ISSN 1574-7891
Publisher: Elsevier BV
DOI: 10.1002/1878-0261.12766

Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic

Author(s): Cadamuro M, Lasagni A, Lamarca A, Fouassier L, Guido M, Sarcognato S, Gringeri E, Cillo U, Strazzabosco M, Marin JJ, Banales JM, Fabris L.
Published in: Expert Opin Investig Drugs., 2021, ISSN 1354-3784
Publisher: Ashley Publications Ltd.
DOI: 10.1080/13543784.2021.1880564

Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system.

Author(s): Angela Lamarca, Alvaro Santos‐Laso, Kirsten Utpatel, Adelaida La Casta, Simone Stock, Alejandro Forner, Jorge Adeva, Trine Folseraas, Luca Fabris, Rocio IR Macias, Marcin Krawczyk, Marek Krawczyk, Vincenzo Cardinale, Chiara Braconi, Domenico Alvaro, Matthias Evert, Jesus M. Banales, Juan W Valle
Published in: Hepatology, 2020, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.31598

Current and novel therapeutic opportunities for systemic therapy in biliary cancer

Author(s): José J. G. Marin, Maria Giuseppina Prete, Angela Lamarca, Simona Tavolari, Ana Landa-Magdalena, Giovanni Brandi, Oreste Segatto, Arndt Vogel, Rocío I. R. Macias, Pedro M. Rodrigues, Adelaida La Casta, Joachim Mertens, Cecilia M. P. Rodrigues, Maite G. Fernandez-Barrena, Ana Da Silva Ruivo, Marco Marzioni, Giulia Mentrasti, Pilar Acedo, Patricia Munoz-Garrido, Vincenzo Cardinale, Jesus M. Banales
Published in: British Journal of Cancer, 123/7, 2020, Page(s) 1047-1059, ISSN 0007-0920
Publisher: Nature Publishing Group
DOI: 10.1038/s41416-020-0987-3

A look back at cholangiocarcinoma in Finland

Author(s): Izquierdo-Sanchez L, Banales JM, Rodrigues PM.
Published in: United European Gastroenterol J, 2021, ISSN 2050-6414
Publisher: SAGE Publications Inc.
DOI: 10.1002/ueg2.12157

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge

Author(s): Mattos ÂZ, Debes JD, Dhanasekaran R, Benhammou JN, Arrese M, Patrício ALV, Zilio AC, Mattos AA.
Published in: World Journal of Hepatology, 2021, ISSN 1948-5182
Publisher: Baishideng Publishing Group
DOI: 10.4254/wjh.v13.i9.1107

Combination therapies for targeting FGFR2 fusions in cholangiocarcinoma.

Author(s): Saborowski A, Vogel A, Segatto O.
Published in: Trends Cancer., 2021, ISSN 2405-8033
Publisher: Cell Press
DOI: 10.1016/j.trecan.2021.11.001

Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study

Author(s): Boris J. B. Beudeker, Zwier M. A. Groothuismink, Robert A. Man, Caroline D. M. Witjes, Annemiek A. Eijk, Andre Boonstra, Milan J. Sonneveld
Published in: Journal of Viral Hepatitis, 28/1, 2021, Page(s) 205-208, ISSN 1352-0504
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/jvh.13394

HPB cancers in older patients | inclusion of older/senior patients in clinical trials

Author(s): Alison Backen, Angela Lamarca, Richard A. Hubner, Mairéad G. McNamara, Juan W. Valle
Published in: European Journal of Surgical Oncology, 47/3, 2021, Page(s) 597-602, ISSN 0748-7983
Publisher: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.ejso.2020.11.002

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma

Author(s): Rocio I. R. Macias, Luis Muñoz-Bellvís, Anabel Sánchez-Martín, Enara Arretxe, Ibon Martínez-Arranz, Ainhoa Lapitz, M. Laura Gutiérrez, Adelaida La La Casta, Cristina Alonso, Luis M. González, Matias A. Avila, Maria L. Martinez-Chantar, Rui E. Castro, Luis Bujanda, Jesus M. Banales, Jose J. G. Marin
Published in: Cancers, 12/6, 2020, Page(s) 1433, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12061433

Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients

Author(s): Patricia García, Angela Lamarca, Javier Díaz, Enrique Carrera, Juan Roa
Published in: Cancers, 12/12, 2020, Page(s) 3670, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12123670

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Author(s): Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Ragg
Published in: Nature Reviews Gastroenterology & Hepatology, 17/9, 2020, Page(s) 557-588, ISSN 1759-5045
Publisher: Nature Publishing Group
DOI: 10.1038/s41575-020-0310-z

Author(s): Chimaobi M. Anugwom, Manon Allaire, Sheikh Mohammad Fazle Akbar, Amir Sultan, Steven Bollipo, Angelo Z. Mattos, Jose D. Debes
Published in: Hepatoma Research, 2021, ISSN 2454-2520
Publisher: OAE publishing
DOI: 10.20517/2394-5079.2021.06

Role of lncRNAs in the development of an aggressive phenotype in gallbladder cancer

Author(s): Pablo Pérez-Moreno, Ismael Riquelme, Priscilla Brebi, Juan Carlos Roa
Published in: Journal of Clinical Medicine, 2021, ISSN 2077-0383
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/jcm10184206

Ivosidenib: an investigational drug for the treatment of biliary tract cancers

Author(s): Angelos Angelakas, Angela Lamarca, Richard a Hubner, Mairéad G McNamara, Juan W. Valle
Published in: Expert Opinion on Investigational Drugs, 30/4, 2021, Page(s) 301-307, ISSN 1354-3784
Publisher: Ashley Publications Ltd.
DOI: 10.1080/13543784.2021.1900115

Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials.

Author(s): Héloïse Bourien, Angela Lamarca, Mairéad G McNamara, Richard A Hubner, Juan W Valle, Julien Edeline
Published in: Expert Opinion on Investigational Drugs, 2021, ISSN 1354-3784
Publisher: Ashley Publications Ltd.
DOI: 10.1080/13543784.2021.1964470

Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation

Author(s): Sabine K. Urban, Hanna Sänger, Marcin Krawczyk, Henrike Julich‐Haertel, Arnulf Willms, Joanna Ligocka, Mikel Azkargorta, Tudor Mocan, Christoph Kahlert, Beata Kruk, Krzysztof Jankowski, Waldemar Patkowski, Marek Krawczyk, Krzysztof Zieniewicz, Wacław Hołówko, Łukasz Krupa, Mateusz Rzucidło, Krzysztof Gutkowski, Wojciech Wystrychowski, Robert Król, Joanna Raszeja‐Wyszomirska, Artur Słom
Published in: Liver International, 40/12, 2020, Page(s) 3103-3116, ISSN 1478-3223
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/liv.14585

Locoregional therapies in patients with intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.

Author(s): Julien Edeline, Angela Lamarca, Mairéad G McNamara, Timothy Jacobs, Richard A Hubner, Dan Palmer, Bas Groot Koerkamp, Philip Johnson, Boris Guiu and Juan W Valle.
Published in: Cancer Treatment reviews, 2021, ISSN 0305-7372
Publisher: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.ctrv.2021.102258

Advances in systemic therapy for the first-line treatment of unresectable HCC

Author(s): Arndt Vogel, Melanie Bathon, Anna Saborowski
Published in: Expert Review of Anticancer Therapy, 2021, ISSN 1473-7140
Publisher: Future Drugs Ltd.
DOI: 10.1080/14737140.2021.1882855

Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America

Author(s): Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, Bolomo A, Carlino Y, Bombassaro IZ, Wiltgen D, Castillo LT, Díaz K, Acuña J, Manero E, Prieto J, Carrera E, Díaz-Ferrer J, Debes JD
Published in: Can J Gastroenterol Hepatol, 2021, ISSN 2291-2789
Publisher: Pulsus Group Inc.
DOI: 10.1155/2021/1622533

Insights into NAFLD heterogeneity

Author(s): Marco Arrese, MD, Juan Pablo Arab, MD, Francisco Barrera, MD, Ben Kaufmann, MD, Luca Valenti; MD, PhD, Ariel E. Feldstein, MD
Published in: Seminars in Liver Disease, 2021, ISSN 1098-8971
Publisher: Thieme
DOI: 10.1055/s-0041-1730927

Implicit bias in region-dependent publication potential can partly be counteracted by Academic collaboration

Author(s): Maikel P. Peppelenbosch, Carmen V. Ferreira
Published in: Clinical Gastroenterology and Hepatology, 2021, ISSN 1542-3565
Publisher: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.cgh.2021.04.001

Current impact of viral hepatitis on liver cancer development: The challenge remains

Author(s): """Ângelo Zambam de Mattos, Jose D Debes, Andre Boonstra, Ju-Dong Yang, Domingo C Balderramo, Giovana D P Sartori, Angelo Alves de Mattos"""
Published in: World J Gastroenterol, 2021, ISSN 1007-9327
Publisher: W J G Press
DOI: 10.3748/wjg.v27.i24.3556

Reply to “Does multiple intrahepatic cholangiocarcinoma worsen prognosis as “M1” stage?”; multiple primaries vs liver metastases

Author(s): Angela Lamarca, Alvaro Santos‐Laso, Kirsten Utpatel, Adelaida La Casta, Simone Stock, Alejandro Forner, Jorge Adeva, Trine Folseraas, Luca Fabris, Rocio IR Macias, Marcin Krawczyk, Marek Krawczyk, Vincenzo Cardinale, Chiara Braconi, Domenico Alvaro, Matthias Evert, Jesus M. Banales, Juan W Valle
Published in: Hepatology, 2021, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.31740

Hepatobiliary cancers in South America: disparity strikes

Author(s): Jose D Debes, Andre Boonstra, Domingo Balderramo, Angelo Z Mattos, Marco Arrese, Juan C. Roa, Juan W. Valle, Jesus M. Banales, Enrique Carrera, Pablo A. Romagnoli, Jhon E. Prieto, Bettina E. Hansen, Arndt Vogel, Angela Lamarca
Published in: The Lancet Gastroenterology & Hepatology, 4/8, 2019, Page(s) 581, ISSN 2468-1253
Publisher: Elsevier
DOI: 10.1016/s2468-1253(19)30188-8

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis

Author(s): Jesus M. Banales, Mercedes Iñarrairaegui, Ander Arbelaiz, Piotr Milkiewicz, Jordi Muntané, Luis Muñoz-Bellvis, Adelaida La Casta, Luis M. Gonzalez, Enara Arretxe, Cristina Alonso, Ibon Martínez-Arranz, Ainhoa Lapitz, Alvaro Santos-Laso, Matias A. Avila, Maria L. Martínez-Chantar, Luis Bujanda, Jose J.G. Marin, Bruno Sangro, Rocio I.R. Macias
Published in: Hepatology, 70/2, 2019, Page(s) 547-562, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.30319

Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor

Author(s): Patricia García, Carolina Bizama, Lorena Rosa, Jaime A. Espinoza, Helga Weber, Javier Cerda-Infante, Marianela Sánchez, Viviana P. Montecinos, Justo Lorenzo-Bermejo, Felix Boekstegers, Marcela Dávila-López, Francisca Alfaro, Claudia Leiva-Acevedo, Zasha Parra, Diego Romero, Sumie Kato, Pamela Leal, Marcela Lagos, Juan Carlos Roa
Published in: Biological Research, 53/1, 2020, ISSN 0717-6287
Publisher: Biological Research (BMC)
DOI: 10.1186/s40659-020-00282-7

Hepatocellular Carcinoma: Unraveling the Role of Occult Hepatitis B Virus Infection

Author(s): Ângelo Z. Mattos, Angelo A. Mattos, Jose D. Debes
Published in: Clinical Gastroenterology and Hepatology, 2020, ISSN 1542-3565
Publisher: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.cgh.2020.03.028

Diagnostic and prognostic biomarkers in cholangiocarcinoma

Author(s): Rocio I. R. Macias, Miroslaw Kornek, Pedro M. Rodrigues, Nuno A. Paiva, Rui E. Castro, Sabine Urban, Stephen P. Pereira, Massimiliano Cadamuro, Christian Rupp, Sven H. Loosen, Tom Luedde, Jesus M. Banales
Published in: Liver International, 39/S1, 2019, Page(s) 108-122, ISSN 1478-3223
Publisher: Blackwell Publishing Inc.
DOI: 10.1111/liv.14090

Hepatocellular carcinoma, a unique tumor with a lack of biomarkers

Author(s): Jose D. Debes, Enrique Carrera, Angelo Z. Mattos, Jhon E. Prieto, Andre Boonstra
Published in: Annals of Hepatology, 18/6, 2019, Page(s) 786-787, ISSN 1665-2681
Publisher: Ediciones Medicina y Cultura
DOI: 10.1016/j.aohep.2019.07.009

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer

Author(s): Patricia García, Lorena Rosa, Sergio Vargas, Helga Weber, Jaime A. Espinoza, Felipe Suárez, Isabel Romero-Calvo, Nicole Elgueta, Vanessa Rivera, Bruno Nervi, Javiera Obreque, Pamela Leal, Eduardo Viñuela, Gloria Aguayo, Sabrina Muñiz, Alfredo Sagredo, Juan C. Roa, Carolina Bizama
Published in: Cancers, 12/4, 2020, Page(s) 778, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12040778

Author(s): Jose D. Debes, Andre Boonstra, Robert J. Knegt
Published in: Hepatology, 71/3, 2020, Page(s) 774-776, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.31170

Circulating biomarkers for early detection of hepatocellular carcinoma

Author(s): Boris J. B. Beudeker, Andre Boonstra
Published in: Therapeutic Advances in Gastroenterology, 13, 2020, Page(s) 175628482093173, ISSN 1756-2848
Publisher: SAGE
DOI: 10.1177/1756284820931734

Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience.

Author(s): Welland S, deCastro T, Bathon M, Wirth TC, Reineke-Plaaß T, Saborowski M, Lehmann U, Saborowski A, Vogel A.
Published in: Journal of Cancer Research and Clinical Oncology, 2021, ISSN 0171-5216
Publisher: Springer Verlag
DOI: 10.1007/s00432-021-03774-5

Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy

Author(s): Mattos ÂZ, Debes JD, Boonstra A, Vogel A, Mattos AA
Published in: World Journal of Gastrointestinal Oncology, 2021, ISSN 1948-5204
Publisher: Baishideng Publishing Group
DOI: 10.4251/wjgo.v13.i9.1132

Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands.

Author(s): Beudeker BJB, Voermans JJC, Geurtsvankessel CH, de Knegt RJ, Kuhlemann T, Boonstra A, van der Eijk AA
Published in: Journal of Clinical Virology, 2021, ISSN 1386-6532
Publisher: Elsevier BV
DOI: 10.1016/j.jcv.2021.104870

Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation

Author(s): Angela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, Adelaida La Casta, Simone Stock, Alejandro Forner, Jorge Adeva, Trine Folseraas, Luca Fabris, Rocio IR Macias, Marcin Krawczyk, Marek Krawczyk, Vincenzo Cardinale, Chiara Braconi, Domenico Alvaro, Matthias Evert, Jesus M. Banales, Juan W Valle
Published in: Hepatology, 2021, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.
DOI: 10.1002/hep.31904

Current and Future Systemic Therapies in Biliary Tract Cancer

Author(s): Arndt Vogel, Anna Saborowski
Published in: Visceral Medicine, 37/1, 2021, Page(s) 32-38, ISSN 2297-4725
Publisher: Karger international
DOI: 10.1159/000513969

Immunotherapies in clinical development for biliary tract cancer

Author(s): Arndt Vogel, Melanie Bathon, Anna Saborowski
Published in: Expert Opinion on Investigational Drugs, 30/4, 2021, Page(s) 351-363, ISSN 1354-3784
Publisher: Ashley Publications Ltd.
DOI: 10.1080/13543784.2021.1868437

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma

Author(s): Noe Rico Montanari, Chimaobi M. Anugwom, Andre Boonstra and Jose D. Debes
Published in: Cancers, 2021, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13194876

Pathogenesis of Cholangiocarcinoma

Author(s): Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, Irene Olaizola, Alona Agirre-Lizaso, Ana Landa, Luis Bujanda, Maria J. Perugorria, Jesus M. Banales
Published in: Annual Review of Pathology: Mechanisms of Disease, 16/1, 2021, Page(s) 433-463, ISSN 1553-4006
Publisher: Annual Reviews, Inc.
DOI: 10.1146/annurev-pathol-030220-020455

Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic

Author(s): Massimiliano Cadamuro, Alberto Lasagni, Angela Lamarca, Laura Fouassier, Maria Guido, Samantha Sarcognato, Enrico Gringeri, Umberto Cillo, Mario Strazzabosco, Jose JG Marin, Jesus M Banales, Luca Fabris
Published in: Expert Opinion on Investigational Drugs, 30/4, 2021, Page(s) 377-388, ISSN 1354-3784
Publisher: Ashley Publications Ltd.
DOI: 10.1080/13543784.2021.1880564

Serum Biomarkers for the Prediction of Hepatocellular Carcinoma

Author(s): José Debes, Pablo Romagnoli, Jhon Prieto, Marco Arrese, Angelo Mattos, André Boonstra
Published in: Cancers, 13/7, 2021, Page(s) 1681, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13071681

Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis

Author(s): Ainhoa Lapitz, Ander Arbelaiz, Colm J. O’Rourke, Jose L. Lavin, Adelaida La Casta, Cesar Ibarra, Juan P. Jimeno, Alvaro Santos-Laso, Laura Izquierdo-Sanchez, Marcin Krawczyk, Maria J. Perugorria, Raul Jimenez-Aguero, Alberto Sanchez-Campos, Ioana Riaño, Esperanza Gónzalez, Frank Lammert, Marco Marzioni, Rocio I.R. Macias, Jose J. G. Marin, Tom H. Karlsen, Luis Bujanda, Juan M. Falcón-Pérez,
Published in: Cells, 9/3, 2020, Page(s) 721, ISSN 2073-4409
Publisher: MDPI
DOI: 10.3390/cells9030721

Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management

Author(s): Amedeo Lonardo, Juan Pablo Arab, Marco Arrese
Published in: Advances in Therapy, 2021, ISSN 0741-238X
Publisher: Health Communications, Inc.
DOI: 10.1007/s12325-021-01690-1

Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach

Author(s): Jesús M. Urman, José M. Herranz, Iker Uriarte, María Rullán, Daniel Oyón, Belén González, Ignacio Fernandez-Urién, Juan Carrascosa, Federico Bolado, Lucía Zabalza, María Arechederra, Gloria Alvarez-Sola, Leticia Colyn, María U. Latasa, Leonor Puchades-Carrasco, Antonio Pineda-Lucena, María J. Iraburu, Marta Iruarrizaga-Lejarreta, Cristina Alonso, Bruno Sangro, Ana Purroy, Isabel Gil, L
Published in: Cancers, 12/6, 2020, Page(s) 1644, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12061644

Deliverables

Publications

Share this page

Download